Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0003 USD | +417.24% | -.--% | +200.00% |
2017 | Arno Therapeutics, Inc. Terminates Licensing Agreement with Ohio State University | CI |
2017 | Arno Therapeutics Seeks Acquisitions | CI |
Performance
1 day | +417.24% | ||
3 months | +200.00% | ||
6 months | +200.00% | ||
Current year | +200.00% | ||
1 year | +200.00% | ||
3 years | -94.00% | ||
5 years | -80.00% | ||
10 years | -99.98% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Biopharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+417.24% | -.--% | +200.00% | +200.00% | 14.8K | ||
+0.47% | +1.46% | -1.64% | -7.30% | 90.28B | ||
-1.32% | -5.70% | -1.97% | -4.12% | 39.5B | ||
+0.42% | -5.55% | -15.47% | -26.76% | 31.71B | ||
-0.70% | +0.43% | +61.28% | +53.13% | 26.41B | ||
-1.44% | -3.40% | -22.81% | -15.88% | 14.34B | ||
-0.10% | +0.10% | -8.82% | -8.52% | 12.89B | ||
-1.62% | -0.35% | -11.77% | -2.45% | 11.8B | ||
-0.36% | -5.11% | -45.97% | -32.13% | 10.95B | ||
-0.14% | -1.78% | +3.30% | +19.70% | 8.85B | ||
+1.80% | -8.34% | -13.92% | -2.52% | 7.53B | ||
-2.00% | -2.11% | +88.83% | +307.45% | 7.41B | ||
+0.12% | +0.46% | -8.38% | +9.00% | 6.92B | ||
-2.88% | -3.98% | -9.57% | +2.79% | 6.55B | ||
-0.42% | -3.15% | -11.50% | +4.42% | 6.48B | ||
-0.60% | -5.84% | -39.54% | -17.64% | 6.15B | ||
Average | +25.53% | -2.25% | +10.13% | +29.95% | ||
Weighted average by Cap. | -0.30% | -1.59% | -0.13% | +5.03% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +200.00% | ||
2023 | +9,900.00% | ||
2022 | -99.95% | ||
2021 | -12.50% | ||
2020 | +33.33% | ||
2019 | +20.00% | ||
2018 | +25.00% | ||
2017 | -99.36% | ||
2016 | -45.80% | ||
2015 | -48.28% | ||
2014 | -76.18% | ||
2013 | -30.00% | ||
2012 | -66.67% | ||
2011 | +194.12% | ||
2010 | -49.00% | ||
2009 | -50.00% | ||
2008 | -.--% |
- Stock Market
- Equities
- ARNI Stock
- Quotes Arno Therapeutics, Inc.